Pharmacovigilance Market Scope And Analysis

  • Report Code : TIPRE00003127
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi dell'ambito del mercato della farmacovigilanza e dei concorrenti entro il 2025-2031

Buy Now

Pharmacovigilance Market Report Pharmacovigilance Market Size and Share Pharmacovigilance Market Scope and Analysis

Pharmacovigilance Market Report Scope

Report Attribute Details
Market size in XX milioni di dollari USA nel 2024
Market Size by XX milioni di dollari entro il 2031
Global CAGR ()
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Fase di sperimentazione clinica
  • preclinica
  • fase I
  • fase II
  • fase III
  • fase IV
By Fornitore di servizi
  • outsourcing interno ed esterno
By Tipo di metodo
  • segnalazione spontanea
  • segnalazione ADR intensificata
  • segnalazione spontanea mirata
  • monitoraggio degli eventi di coorte
  • EHR Mining
By Utente finale
  • ospedali
  • organizzazioni di ricerca
  • aziende farmaceutiche e biotecnologiche
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Accenture
  • Bristol-Myers Squibb Company
  • Linical Accelovance
  • Cognizant
  • Covance Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc.
  • ICON plc
  • Capgemini (IGATE Corporation)